Motorola Solutions Inc vs Philip Morris International Inc. — how do they compare? Motorola Solutions Inc trades at $405.33 (market cap $68.13B), while Philip Morris International Inc. trades at $192.12 (market cap $300.37B). The key difference: Philip Morris International Inc. is far larger — about 4.4× Motorola Solutions Inc's market cap, and Philip Morris International Inc. pays the higher dividend (3.05%). Which is the better fit depends on your goals.
| MSI | PM | |
|---|---|---|
Market Cap | $68.13B | $300.37B |
Sector | Technology | Consumer Staples |
52-Week High | $490.30 | $192.98 |
52-Week Low | $363.83 | $144.33 |
Enterprise Value | $76.83B | $346.86B |
Dividend Yield | 1.18% | 3.05% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Philip Morris International (PM) trades at $192.98, up 1.65% today, near the analyst consensus price target of $194. The stock shows a bullish technical trend with strong moving average support. Fundamentally, the company reported robust 2025 results with revenue of $40.65 billion and net income of $11.35 billion, though recent news highlights a $500 million impairment charge and reduced profit guidance for 2026 due to cost pressures.
The outlook remains cautiously optimistic with 68% of analysts rating it a Buy, but investors face headwinds from currency volatility, rising illicit tobacco trade in Europe, and margin compression. The stock's valuation at a P/E of 27.13 appears full priced, requiring continued execution to justify further upside.
Trailing returns across standard periods
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →